UBS AM’s Achaogen Inc AKAO Stock Holding History

UBS AM’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30,496	Closed	-$122K	–	2853
2018 Q3	$122K	Hold	30,496	–	–	﹤0.01%	2509
2018 Q2	$264K	Buy	+30,496	New	+$372K	﹤0.01%	2357

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM's AKAO Position: Q4 2018 in Review

UBS AM sold out of Achaogen Inc (AKAO) in Q4 2018, closing a stake of 30,496 shares — an estimated $122K sold.

UBS AM first reported a position in AKAO in Q2 2018 and held it in 2 quarters. The position peaked at $264K in Q2 2018. 78 funds tracked by Wall St. Rank hold AKAO as of Q4 2018.

UBS AM reported no remaining Achaogen Inc position as of Q4 2018 after selling out during the quarter.
UBS AM sold 30,496 Achaogen Inc shares in Q4 2018, an estimated $122K.
UBS AM first reported a position in Achaogen Inc in Q2 2018 and held it in 2 quarters.
UBS AM's Achaogen Inc position peaked at $264K in Q2 2018.
78 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2018.

Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.